Roger Jeffs - 03 Apr 2022 Form 4 Insider Report for Liquidia Corp (LQDA)

Role: Chief Executive Officer, Director
Signature: /s/ Roger Jeffs
Issuer symbol: LQDA
Transactions as of: 03 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2022, 16:25:10 UTC
Previous filing: 20 Apr 2022
Next filing: 25 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LQDA	Common Stock	Options Exercise		+47,423	+30%		207,250	03 Oct 2022	Direct	F1, F2
holding	LQDA	Common Stock						46,595	03 Apr 2022	See footnote	F3
holding	LQDA	Common Stock						1,541,667	03 Apr 2022	See footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LQDA	Restricted Stock Unit	Options Exercise	$0	-47,423	-75%	$0.000000	15,807	03 Oct 2022	Common Stock	47,423		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2	On January 3, 2022, the Reporting Person was granted 63,230 RSUs with 25% vesting quarterly through the first anniversary of the grant date. Of those RSUs, a total of 47,423 have vested through October 3, 2022.
F3	The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F4	The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.